Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Singapore for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage Hormone Receptor Positive HER2-Positive Breast Cancer

… of NERLYNX® (neratinib) in Singapore from the Health Sciences Authority … [email protected] KEYWORD: SINGAPORE UNITED STATES NORTH AMERICA ASIA … TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Puma Biotechnology, Inc. Copyright Business …